Paper6325140
Valproic acid and metabolites: pharmacological and toxicological studies.
Nau H and 1 other. Epilepsia, 1984. Cited by 118 papers, by iCite.
Cite this record
ConductScience Library. Valproic acid and metabolites: pharmacological and toxicological studies. Papers, record 6325140. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6325140
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Valproic Acid | Major topic |
| Abnormalities, Drug-Induced | |
| Animals | |
| Brain | |
| Chemical Phenomena | |
| Chemical and Drug Induced Liver Injury | |
| Chemistry | |
| Dogs | |
| Epilepsy | |
| Humans | |
| Rodentia | |
| Synaptic Transmission | |
| gamma-Aminobutyric Acid |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36894749 | Embryonic exposure to acetyl-L-carnitine protects against valproic acid-induced cardiac malformation in zebrafish model. | Amino Acids | 2023 | https://conductscience.org/library/papers/36894749 | PubMed |
| 29715267 | Comparative metabolomics of aging in a long-lived bat: Insights into the physiology of extreme longevity. | PLoS One | 2018 | https://conductscience.org/library/papers/29715267 | PubMed |
| 29403970 | Liquid chromatography-tandem mass spectrometry method for simultaneous determination of valproic acid and its ene-metabolites in epilepsy patient plasma. | J Pharm Anal | 2016 | https://conductscience.org/library/papers/29403970 | PubMed |
| 24105977 | Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice. | Mol Pharmacol | 2014 | https://conductscience.org/library/papers/24105977 | PubMed |
| 20358691 | Drugs and pharmaceuticals: management of intoxication and antidotes. | EXS | 2010 | https://conductscience.org/library/papers/20358691 | PubMed |
| 18392741 | Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. | J Inherit Metab Dis | 2008 | https://conductscience.org/library/papers/18392741 | PubMed |
| 18072149 | Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity. | J Med Toxicol | 2007 | https://conductscience.org/library/papers/18072149 | PubMed |
| 12269861 | Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. | CNS Drugs | 2002 | https://conductscience.org/library/papers/12269861 | PubMed |
| 8097295 | Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. | Neurochem Res | 1993 | https://conductscience.org/library/papers/8097295 | PubMed |
| 3998768 | Epileptic seizure disorders. Developments in diagnosis and therapy. | J Neurol | 1985 | https://conductscience.org/library/papers/3998768 | PubMed |
| 3312929 | The risk-benefit ratio of anticonvulsant drugs. | Med Toxicol Adverse Drug Exp | 1987 | https://conductscience.org/library/papers/3312929 | PubMed |
| 3149565 | Clinical pharmacokinetics of valproic acid--1988. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3149565 | PubMed |
| 3131628 | Valproate-associated hepatotoxicity and its biochemical mechanisms. | Med Toxicol Adverse Drug Exp | 1988 | https://conductscience.org/library/papers/3131628 | PubMed |
| 3117085 | Placental transfer and neonatal elimination of mono-unsaturated metabolites of valproic acid. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3117085 | PubMed |
| 3108013 | Lack of relationship between sodium valproate-induced adverse effects and the plasma concentration of its metabolite 2-propylpenten-4-oic acid. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3108013 | PubMed |
| 3104022 | Species differences in pharmacokinetics and drug teratogenesis. | Environ Health Perspect | 1986 | https://conductscience.org/library/papers/3104022 | PubMed |
| 2105099 | The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2105099 | PubMed |
| 1570023 | Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats. | Naunyn Schmiedebergs Arch Pharmacol | 1992 | https://conductscience.org/library/papers/1570023 | PubMed |
| 1502015 | Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals. | Pharm Weekbl Sci | 1992 | https://conductscience.org/library/papers/1502015 | PubMed |
| 1502009 | Pharmacokinetics of valproate in pregnancy: mother-foetus-newborn. | Pharm Weekbl Sci | 1992 | https://conductscience.org/library/papers/1502009 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6325140
GET https://conductscience.org/api/papers/v1/6325140/cited_by?page=2